11 November 2026
Hogan Lovells Cadwalader advises BCM Legacy Fund in the design and formation of its fund to invest philanthropic capital in biomedical startups
Advising firms
Deal team
1 lawyer named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Barry Burgdorf | Hogan Lovells Cadwalader | Partner | Not stated | Not stated |
Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- BCM Legacy Fund I, LPInvestor
- Counterparties
- Nemea Therapeutics (Other)